Physician profile
John William Nance
NPI 1306166657
$221,060.15
in general payments reported to CMS, 2019-2025
8 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $23K · 2021: $25K · 2022: $36K · 2023: $48K · 2024: $9,932 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Travel and Lodging: $13K · Food and Beverage: $2,073 · Consulting Fee: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $80,575.00 |
| Travel and Lodging | $12,594.67 |
| Food and Beverage | $2,073.49 |
| Consulting Fee | $939.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $191,036.93 | 2019-2025 | |
| Genentech USA, INC. | $28,542.50 | 2019 | |
| Bayer Healthcare LLC | $939.00 | 2023 | |
| Ge Healthcare | $304.11 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $153.03 | 2025 | Naeotom Alpha |
| Aidoc Medical LTD | $46.88 | 2025 | Briefcase |
| Heartflow, INC. | $22.82 | 2020 | |
| United Therapeutics Corporation | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.